Showing results (221-230 of 268) with videos related to

Sort By:
Pageof 27
Frontiers in Pharmacology|August 18, 2018
Biologically Targeted Magnetic Hyperthermia: Potential and LimitationsDavid Chang, May Lim, Jeroen A C M Goos, et al.
Medical Physics|May 19, 2017
SU-E-J-176: Clinical Evaluations of a Novel Metal Artifact Reduction Technique for Treatment Planning in Radiation TherapyH Li, C Noel, W Thorstad, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|December 4, 2008
A new twist on an old problem: a case of pediatric meningitis caused by multidrug-resistant Streptococcus pneumoniae serotype 19AW Ciccotelli, S Poutanen, S Morris, et al.
Medical Physics|May 8, 2012
Evolving treatment plan quality criteria from institution-specific experienceD Ruan, W Shao, J Demarco, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|May 5, 2022
Open left thoracoabdominal esophagectomy a viable option in the era of minimally invasive esophagectomyF Klevebro, S Han, S Ash, et al.
Macromolecular Rapid Communications|April 7, 2020
pH-Responsive Polymers for Improving the Signal-to-Noise Ratio of Hypoxia PET Imaging with [18 F]FluoromisonidazoleJeroen A C M Goos, Maria Davydova, Nigel Lengkeek, et al.
AIDS (London, England)|December 24, 1998
Randomized, controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patientsU R Hengge, M Goos, S Esser, et al.
Gastrointestinal Endoscopy|March 1, 1996
Expandable versus conventional esophageal prostheses: easier insertion may not preclude subsequent stent-related problemsR A Kozarek, T J Ball, J J Brandabur, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|April 12, 2008
Investigation of the second wave (phase 2) of severe acute respiratory syndrome (SARS) in Toronto, Canada. What happened?M Ofner-Agostini, T Wallington, B Henry, et al.
EJNMMI Research|August 8, 2023
Comparative in vivo biodistribution of cells labelled with [89Zr]Zr-(oxinate)4 or [89Zr]Zr-DFO-NCS using PETIda Friberger, Joachim N Nilsson, Li Lu, et al.
Pageof 27